GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » Cyclically Adjusted PS Ratio

Essex Bio-Technology (HKSE:01061) Cyclically Adjusted PS Ratio : 2.39 (As of Jun. 03, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology Cyclically Adjusted PS Ratio?

As of today (2025-06-03), Essex Bio-Technology's current share price is HK$5.10. Essex Bio-Technology's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 was HK$2.13. Essex Bio-Technology's Cyclically Adjusted PS Ratio for today is 2.39.

The historical rank and industry rank for Essex Bio-Technology's Cyclically Adjusted PS Ratio or its related term are showing as below:

HKSE:01061' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.03   Med: 4.69   Max: 13.42
Current: 2.45

During the past 13 years, Essex Bio-Technology's highest Cyclically Adjusted PS Ratio was 13.42. The lowest was 1.03. And the median was 4.69.

HKSE:01061's Cyclically Adjusted PS Ratio is ranked worse than
54.2% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs HKSE:01061: 2.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Essex Bio-Technology's adjusted revenue per share data of for the fiscal year that ended in Dec24 was HK$2.868. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is HK$2.13 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Essex Bio-Technology Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Essex Bio-Technology's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology Cyclically Adjusted PS Ratio Chart

Essex Bio-Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.15 3.20 2.42 1.28 1.38

Essex Bio-Technology Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 - 1.28 - 1.38

Competitive Comparison of Essex Bio-Technology's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essex Bio-Technology's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's Cyclically Adjusted PS Ratio falls into.


;
;

Essex Bio-Technology Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Essex Bio-Technology's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5.10/2.13
=2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Essex Bio-Technology's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Essex Bio-Technology's adjusted Revenue per Share data for the fiscal year that ended in Dec24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=2.868/114.8925*114.8925
=2.868

Current CPI (Dec24) = 114.8925.

Essex Bio-Technology Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201512 1.154 100.600 1.318
201612 1.368 102.600 1.532
201712 1.578 104.500 1.735
201812 1.956 106.500 2.110
201912 2.118 111.200 2.188
202012 1.621 111.500 1.670
202112 2.720 113.108 2.763
202212 2.198 115.116 2.194
202312 2.916 114.781 2.919
202412 2.868 114.893 2.868

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Essex Bio-Technology  (HKSE:01061) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Essex Bio-Technology Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Essex Bio-Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Executives
Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin 2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines